High-content imaging of live microglia-containing Alzheimer's disease brain organoids

Age-dependent DS-AD-associated phenotypes emerge within T21 microglia-containing brain organoids, including Aβ neuropathology, neurodegeneration, and glial cell dysregulation.

• Why it matters: Modeling Alzheimer’s disease in vitro is limited by the lack of an immune-competent 3D human model that supports high-throughput, real-time longitudinal readouts.
• What they did: The study used PyrPeg to selectively monitor Aβ aggregation and calcein AM plus propidium iodide to assess viability in microglia-containing cerebral organoids (MCOs), then analyzed T21 MCOs across age.
• The result: The platform enables real-time, multiplexed tracking of disease progression in these organoids, supporting scalable longitudinal studies of mechanisms and targeted treatment approaches.